Help patients get the answers they need.

Serology tests may miss
patients who had COVID-19.
T cells have the answer.

Help patients get the answers they need.

Serology tests may miss
patients who had COVID-19.
T cells have the answer.

T-Detect COVID is now cleared under the FDA Emergency Use Authority (EUA).*

T-cells vs. antibodies

The T-Detect COVID test is a highly sensitive and specific test that can detect the specific T cell signature in response to SARS-CoV-2, the virus that causes COVID-19.

In studies, the T-Detect COVID test outperformed leading antibody tests.1

Sensitivity

Specificity

Sensitivity based on Positive Percent Agreement (PPA) with PCR testing.

Learn more

Read the T-Detect COVID physician brochure.

Physician Brochure

How it works

1. Partner

Sign a business agreement, establish an account, and prepay for test kits. Contact us to learn more.

2. Blood draw

Place a patient order, collect blood sample, and ship the kit back to Adaptive.

3. Results

Receive results via our secure portal approximately 7-10 days from shipment of blood sample (including 5-7 days for lab processing*).

* Lab processing begins once all required provider and patient information is validated.

Special self-pay test price $150

Additional fees include test authorization ($9) and blood draw (on-site lab: $60 or in-home: $140).

Contact Us

The price does not represent the usual and customary charge for the T-Detect COVID test and is subject to change. The T-Detect COVID test is FSA/HSA eligible. 

Frequently asked questions

How does T-Detect COVID work?

T cells are the first responders of the adaptive immune system and activate the antibody response. While antibodies to SARS-CoV-2 naturally wane and are detectable in the shorter term, T cell responses can persist in the blood long after antibody responses wane.1,2,4

The T-Detect COVID test can detect T cells in a blood sample that can remain for up to several months after symptoms appear.1,2,3

  1. Zuo J, et al. Robust SARS-CoV-2-specific T-cell immunity is maintained at six months following primary infection. bioRxiv. 2020.
  2. Adaptive data on file.
  3. Ng, O, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016.
  4. Dalai, S, et al. Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection. medRxiv. 2020.

* T-Detect COVID is not FDA cleared or approved. It is authorized for emergency use under an Emergency Use Authorization.

This test has not been FDA cleared or approved but has been authorized for emergency use by FDA under an EUA.

Testing of venous whole blood using K2 EDTA specimens is limited to laboratories designated by Adaptive Biotechnologies Corporation that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, and meets the requirements to perform high complexity tests as described in the T-Detect COVID Test Standard Operating Procedure that was reviewed by the FDA under this EUA.

This test has been authorized only for detecting and identifying the presence of an adaptive T-cell immune response to SARS-CoV-2, not for any other viruses or pathogens.

The emergency use of this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

T-Detect™ COVID is not indicated for use in patients under age 18.

For Patients

The T-Detect COVID test can detect past COVID-19 infections for up to several months.

Learn More

For Employers

The T-Detect COVID test can help your employees get the answers they need.

For Researchers

The T-Detect COVID test can support your research due to its high sensitivity and specificity.

References

  1. Dalai, S, et al. Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection. medRxiv. 2020.
  2. Adaptive data on file.